We are live on ! Find out more
SNOAW

Sonoma Pharmaceuticals, Inc. Warrants
SNOAW

Delisted

SNOAW was delisted on the 22nd of January, 2020.

Back to rankings

2 hedge funds and large institutions have $1K invested in Sonoma Pharmaceuticals, Inc. Warrants in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 3 → 2 (-1)

89% less capital invested

Capital invested by funds: $9K → $1K (-$8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$6K
2
UBS Group
UBS Group
Switzerland
-$1.51K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$1K – – –
VF
2
Virtu Financial
New York
– -$6K -14,811 Closed
UBS Group
3
UBS Group
Switzerland
– -$1.51K -3,579 -97%

SNOAW Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q1 2018, worth a combined $1K — down 89% from $9K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SNOAW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Virtu Financial, exiting entirely with an estimated $6K sold.

  • 2 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q1 2018, down from 3 in Q4 2017.
  • Funds reported $1K of Sonoma Pharmaceuticals, Inc. Warrants stock for Q1 2018, down 89% quarter-over-quarter.
  • 0 funds opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q1 2018 and 1 closed out, a net change of -1 holder.
  • The largest Sonoma Pharmaceuticals, Inc. Warrants seller in Q1 2018 was Virtu Financial, an estimated $6K sold.

Based on aggregated 13F filings for Q1 2018.